MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
99.74
+0.02
+0.02%
After Hours: 99.54 -0.2 -0.20% 19:47 09/25 EDT
OPEN
99.92
PREV CLOSE
99.72
HIGH
99.99
LOW
99.72
VOLUME
952.39K
TURNOVER
--
52 WEEK HIGH
111.86
52 WEEK LOW
49.67
MARKET CAP
6.51B
P/E (TTM)
24.13
1D
5D
1M
3M
1Y
5Y
1D
Notable ETF Outflow Detected - AVUV, MATX, GATX, LNTH
NASDAQ · 2d ago
Lantheus gains approval of Bravnesta, generic competitor to Lutathera
Seeking Alpha · 4d ago
FDA Approves Lantheus' Bravnetsa As Equivalent To Lutathera For Neuroendocrine Tumors
NASDAQ · 4d ago
Lantheus announces U.S. FDA granted final approval for Bravnesta
TipRanks · 4d ago
Lantheus withdraws, resubmits HSR filing for Curium acquisition
Seeking Alpha · 5d ago
Lantheus Merger Advances with Renewed Antitrust Review
TipRanks · 5d ago
Weekly Report: what happened at LNTH last week (0914-0918)?
Weekly Report · 5d ago
Novartis' Lutathera now facing generic competition from Cirium's Bexlutry
Seeking Alpha · 09/15 20:54
More
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. Its product categories include oncology, neurology, cardiology, and strategic partnerships and others. Its products include PYLARIFY, Neuraceq, and DEFINITY. PYLARIFY TruVu is indicated for PET imaging of PSMA-positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy, or suspected recurrence based on elevated serum prostate-specific antigen (PSA). Neuraceq is an Alzheimer's disease radiodiagnostic. Its commercial products are used by cardiologists, internists, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists across a range of clinical care settings. Its diagnostic products provide information that enables healthcare professionals (HCPs) to better detect, characterize, or rule out diseases.

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.